Currently out of the existing stock ratings of Navin Jacob, 33 are a HOLD (45.21%), 36 are a BUY (49.32%), 4 are a SELL (5.48%).
Analyst Navin Jacob, has had 73.15% of price targets met with an average potential upside of 22.5%, reached in 513 days on average. Previously, Navin Jacob worked at UBS, DEUTSCHE BANK.
Navin Jacob has documented 143 price targets and ratings displayed on 19 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ABBV, AbbVie at 02-Feb-2025.
Analyst best performing recommendations are on RAPT.
The best stock recommendation documented was for RAPT on 11/25/2019. The price target of $208 was fulfilled within 4 days with a profit of $27.76 (11.77%), with a performance score of 29.44.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Feb-2026
$335
$39.97 (13.55%)
$325
3 days ago
(15-Nov-2026)
Buy Since 17-Nov-2020
$338
$42.97 (14.56%)
$282
17 days ago
(01-Nov-2026)
20/21 (95.24%)
$43.11 (14.62%)
335
Buy Since 07-Dec-2021
$340
$44.97 (15.24%)
$300
17 days ago
(01-Nov-2026)
11/13 (84.62%)
$45.11 (15.30%)
479
Buy Since 05-Apr-2022
$346
$50.97 (17.28%)
$310
17 days ago
(01-Nov-2026)
33/35 (94.29%)
$51.11 (17.33%)
486
Buy Since 15-Nov-2023
$325
$29.97 (10.16%)
$290
17 days ago
(01-Nov-2026)
32/33 (96.97%)
$30.11 (10.21%)
244